Gene expression analysis in N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mice model of Parkinson's disease using cDNA microarray: Effect of R-apomorphine

Journal of Neurochemistry

Volumn 78, Issue 1, 2001, Pages 1-12

  Grünblatt, Edna ^a   Mandel, Silvia ^a   Maor, Gila ^a   Youdim, Moussa B H ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Apomorphine; cDNA expression array; In situ hybridization; N methyl 4 phenyl 1,2,3,6 tetrahydropyridine; Parkinson's disease; Quantitative real time RT PCR

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; APOMORPHINE; COMPLEMENTARY DNA; GLUTAMIC ACID; IRON CHELATE; NEUROTROPHIC FACTOR; SCAVENGER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CYCLE; CONTROLLED STUDY; DRUG EFFECT; GENE EXPRESSION; GENE MUTATION; IN SITU HYBRIDIZATION; INFLAMMATION; MALE; MOUSE; NERVE DEGENERATION; NEUROPATHOLOGY; NEUROPROTECTION; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TREATMENT OUTCOME; UNINDEXED SEQUENCE;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; ANIMALS; ANTIPARKINSON AGENTS; APOMORPHINE; DNA, COMPLEMENTARY; DOPAMINE AGENTS; GENE EXPRESSION; IN SITU HYBRIDIZATION; MALE; MICE; MICE, INBRED C57BL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PARKINSON DISEASE; PARKINSON DISEASE, SECONDARY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

ANIMALIA;

EID: 0034941949     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2001.00397.x     Document Type: Article

References (42)

1. Differential gene expression in colon carcinoma cells and tissues detected with a cDNA array
2. Brain dopamine and the syndrome of Parkinson and Huntington. Clinical, morphological and neurochemical correlations
3. IL-1β, IL-2, IL-6 and TNF-α production by peripheral blood mononuclear cells from patients with Parkinson's disease
4. Oxidative stress and nuclear factor-kappaB activation: A reassessment of the evidence in the light of recent discoveries
5. The noncompetitive NMDA-receptor antagonist MK-801 prevents the massive release of glutamate and aspartate from rat striatum induced by 1-methyl-4-phenypyridinium (MPP+)
6. DNA microarrays in drug discovery and development
7. Use of a cDNA microarray to analyze gene expression patterns in human cancer
8. Tissue- and cell type-specific expression of cytochrome P450 1A1 and cytochrome P450 1A2 mRNA in the mouse localized in situ hybridization
9. NMDA receptor activation induces nitric-oxide synthesis from arginine in rat-brain slices
10. Neuroprotective and neurorestorative properties of GDNF
11. Apomorphine is highly potent free radical scavenger in rat mitochondrial fraction
12. Apomorphine enantiomers protect cultured pheochromocytoma (PC12) cells from oxidative stress induced by H2O2 and 6-hydroxydopamine
13. Animal models of Parkinson's disease: An empirical comparison with the phenomenology of the disease in man
14. Exploiting chemical libraries, structure, and genomics in the search for kinase inhibitors
15. Apomorphine protects against MPTP-induced neurotoxicity in mice
16. Epidermal growth factor enhances striatal dopaminergic parameters in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mouse
17. Discovery and analysis of inflammatory disease-related genes using cDNA microarrays
18. Glial cell line-derived neurotrophic factor (GDNF) gene expression in the human brain: A post mortem in situ hybridization study with special reference to Parkinson's disease
19. Nuclear translocation of NF-κB is increased in dopaminergic neurons of patients with Parkinson's disease
20. Low molecular levels of hydrogen peroxide and proteasome inhibitors induce the 60-kDa A170 stress protein in murine peritoneal macrophages
21. Brain Iron and ferritin in Parkinson's and Alzheimer's disease
22. Gene expression profile of aging and its retardation by caloric restriction
23. A human HAP1 homologue. Cloning, expression, and interaction with huntingtin
24. Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson's disease
25. GDND: A glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons
26. Role of iron in NFkB activation and cytokines gene expression by rat hepatic macrophages
27. Functional association of TGF-β receptor II with cyclin B
28. Drug target validation and identification of secondary drug target effects using DNA microarrays
29. Interleukin (IL)-1β, IL-2, IL-4, IL-6 and transforming growth factor-α levels are elevated in ventricular cerebrospinal fluid in juvenile parkinsonian and Parkinson's disease
30. Effects of repeated systemic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) to mice on interleukin-1β and nerve growth factor in the striatum
31. Immunohistochemical evaluation of the neurotoxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on dopaminergic nigrostriatal neurons of young adult mice using dopamine and tyrosine hydroxylase antibodies
32. Down-regulation of cyclin F levels during nerve growth factor-induced differentiation of PC12 cells
33. Cell-cycle arrest and inhibition of G1 cyclin translation by iron in AFT1 - 1up yeast
34. Oxidative damage to mitochondrial DNA in Huntington's disease parietal cortex
35. P450 enzymes and Parkinson's disease: The story so far
36. Characterization of the Hsp110/SSE gene family response to hyperosmolarity and other stresses
37. Reactive oxygen intermediates as apparently widely used messengers in the reactivation of the NF-kappa B transcription factor and HIV-1
38. Structure and chromosomal mapping of the TNF-α inducible endothelial protein 1 (Edp1) gene in the mouse
39. Genetic association between cytochrome P450Ia1 gene and susceptibility to Parkinson's disease
40. The human cytochromes P450 involved in drug metabolism
41. The pivotal role of iron in NF-kappa B activation and nigrostriatal dopaminergic neurodegeneration. Prospects for neuroprotection in Parkinson's disease with iron chelaters